Navigation Links
Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility

ymbol: VOX

Further information about the company is available at www.vastox.com

This document contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "anticipates", "intends", "plans", "seeks", "believes", "estimates", "expects" and similar references to future periods, or by the inclusion of forecasts or projections.

Forward-looking statements are based on the Company's current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward-looking statements. The Company cautions you therefore that you should not rely on any of these forward-looking statements as statements of historical fact or as guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements and regional, national, global political, economic, business, competitive, market and regulatory conditions.

Mark Swallow, Ph.D. Citigate Dewe Rogerson

+44 (0)20 7282 2948 (direct) +44 (0)7903 737703 (mobile) +44 (0)20 7638 9571 (switchboard) +44 (0)20 7282 2811 (fax) 3 London Wall Buildings London Wall London EC2M 5SY UK www.citigatedr.co.uk/pharma_biotech.html


'"/>




Page: 1 2 3

Related medicine technology :

1. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
2. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
3. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
4. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
5. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. President Bush Ignores Americas Plea for Support of Stem Cell Research
8. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
11. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
Post Your Comments:
(Date:10/9/2008)...ence Institute, Navigenics, Affymetrix and,Microso..., Oct. 9 /- A consortium of health ca...rces in a first-of-its-kind,research study to asse...ng,on people who choose to receive such screenings...ertain diseases., Sponsored by Scripps Translatio...
(Date:10/8/2008)...imal Use in Cosmetics and Chemicals Testing, ASHL...day announced,that results of a recently completed...ation study on MatTek,s EpiDerm in vitro human ski... the required sensitivity and,specificity for EpiD...nimal,testing for determining human skin irritatio...
(Date:10/8/2008)...o be Discontinued and Headcount to be Reduced, Sum...o Review; Zanolimumab Program to be Discontinued ... Employees, COPENHAGEN, Octo...EN),announced today that it is discontinuing devel... as a result of a portfolio review and,assessment ...
(Date:10/8/2008)...tency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO,...ceuticals,Corporation (TSX: NVN) today presented p...oprietary Toll-like Receptor 3 agonist, Poly IC-Po...ess 2008 in Lyon, France.,Study results demonstrat...ing the Toll-like Receptor 3 (TLR3) pathway. Data ...
Breaking Medicine Technology:Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5A Magnetic Gift 3A Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens 2737 1A Magnetic Gift 3A Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens 2737 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck 2735 1Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck 2735 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck 2735 3Calling for More Veterinarians 10104 1Calling for More Veterinarians 10104 2MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 1MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 2MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 3MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 4
...going therapeutic cancer vaccine,trials have yet t...uo;s immune system to shrink tumors -- yet patient...e longer and respond,better to subsequent treatmen..., a journal of the American Association for Cancer...earchers asks a,fundamental question: are we looki...
...ewswire-FirstCall/ -- Nuvelo,Inc. (Nasdaq: NUVO) ...gulation with rNAPc2 To Help Eliminate MACE)/TIMI ...nticoagulant protein c2,(rNAPc2) in patients with ...valuating rNAPc2 in mouse models of colorectal,can... of NU172, a,short-acting, direct thrombin inhibit...
Other Medicine Technology:From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 2From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 3Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 2Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst,Congress of the International Society on Thrombosis and Haemostasis 3
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...rsity of Florida, the reason obese kids do not she...playground.// The study says that bullying frequen... been picked on before, such as gym class and spor...sistant professor of psychiatry and pediatrics at ...
...forthcoming issue of the Journal of the Royal Soci...limit the amount of water //that they drink during...like headache, collapse, confusion, memory loss, v...luid accumulation in the lungs or brain. All thes...
...y (IIT) Delhi will showcase over 200 innovations r...aves collector in its annual //technological festi...st not an engineering college providing degrees to... subsequent technological innovations as well," sa...
...as simple as administering stem cell products thro... therapy can help regenerate damaged heart muscle ...the first time, reveals a new study. The distinct...travenous infusion of adult mesenchymal stem cells...
Other Medicine News:Health News:IIT Delhi To Display Its Technological Innovations In 'Open House' 2Health News:Stem Cell Therapy Regenerates Heart Muscle In Heart Attack Patients 2
Introducing the new Platinum 10 concentrator. The Platinum 10 delivers the reliability, performance and value advantage you have come to expect from the Platinum line of concentrators and provides an
...table Oxygen Concentrator is the most compact, lig...than 10 lbs (4.5 kg), this unit was designed to ac...e oxygen patient., ,Operating as a pulse flow... oxygen concentrator and an oxygen conserver in on...
OCD-3000 pnuematic conserving regulator.
...7.5 liters out of your five-liter concentrators. ,...igh-flow patients! , ,In many ways, the OXYMIZER...e standard conservers, because they extend oxygen ...o saturate a patient. However, they do not requir...
Medicine Products: